$2.2 million raised to build VR tools for amblyopia
Treatment for binocular vision disorders is available at more than 90 clinics across the world.
Medical technology company Vivid Vision has announced that it has raised $2.2 million to build Virtual Reality (VR) tools that could be used to treat amblyopia.
The company says its VR treatment for binocular vision disorders is available at more than 90 clinics across the world.
Founded in 2014, Vivid Vision applies virtual reality to the field of vision care. Its founder and CEO, James Blaha, a programmer and lifelong sufferer of amblyopia, started the company after experimenting on himself. Before building the first prototype, Blaha couldn’t read with his weak eye or see in 3D.
Since then, according to Vivid Vision, the vision in Blaha’s weak eye has improved to nearly 20/20. Vivid Vision launched its clinical vision therapy suite in late 2015 for optometrists and ophthalmologists and since then, the 90 clinics using it have treated more than 6,000 patients. On average, treatment lasts eight months, with patients coming one or two times a week to use the VR system.
“It is a unique, far more efficient solution to treat Amblyopia, as well as a wide array of binocular vision dysfunction,” said Dan Fortenbacher, founder of Wow Vision Therapy, which has two locations in Michigan. “The progress the patient makes in breaking through suppression and developing 3D vision has been remarkable with Vivid Vision.”